Autologous Adipose-Derived Stem Cells

3 trials 2 recruiting MMusculoskeletal Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

2 Recruiting

1 Completed trials

1 Sponsors

4 Countries

Phase III

Phase I/II

Phase I (FiH)

Phase III: 1 Phase I/II: 1 Phase I (FiH): 1

Indications tested

Congenital pseudarthrosis 1

Sponsors using this IMP

Novadip Biosciences 3

All trials

3 total

A Study to Assess How Effective and Safe NVD003 is for Treating Patients with Congenital Pseudarthrosis of the Tibia. Recruiting

2025-520998-39-00 Phase III 3 countries Novadip Biosciences
A prospective multicentre single-arm study in adults to evaluate the safety and preliminary efficacy of the autologous 3D osteogenic implant… Recruiting

2024-517762-42-01 Phase I (FiH) 2 countries Novadip Biosciences
A proof of concept study with NVD-003, an autologous osteogenic bone graft, in the treatment of congenital pseudarthrosis of the tibia in pe… Ended

2024-515478-29-00 Phase I/II 1 country Novadip Biosciences

Showing 1–3 of 3 trials

← All drugs A–Z